Generic placeholder image

Current Psychopharmacology

Editor-in-Chief

ISSN (Print): 2211-5560
ISSN (Online): 2211-5579

Late Life Depression: A Diagnostic and Pharmacological Review

Author(s): Carol Dillon, Clara Rodriguez and Fernando E. Taragano

Volume 3, Issue 1, 2014

Page: [32 - 41] Pages: 10

DOI: 10.2174/2211556003666140702185640

Price: $65

Abstract

Late life depression is a prevalent disorder that affects elderly population. However, it is frequently sub diagnosed due to great variability in the sample involved, the definition of depression, the methodology used, and the experience of the evaluator.

Different subtypes of geriatric depression exist, each one with its own clinical characteristics. Depressive symptoms often are accompanied by cognitive impairment. Various diagnostic studies must be done to evaluate late life depression, such as depression scales, neuropsychological test, laboratory analyses and Neuroimages. As regards to treatment, antidepressants are always the first line option, especially IRSS due to its effectiveness and low rates of adverse events. Antipsychotics may provide benefit for agitated, psychotic, or resistant MDD in the elderly. Mood stabilizers are useful in bipolar depression such as lamotrigine, lithium and divalproate. This review aims to define the different subtypes of geriatric depression, describe diagnostic methods and revise recent data about pharmacological treatment.

Keywords: Clinical manifestations, diagnosis, late life depression, treatment.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy